Torsades de pointes

disorder

SNOMED 31722008CUI C0040479

Overview

Torsades de pointes is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Treatments & Interventions

Isoprenaline hydrochloride

substance

Isoprenaline sulfate

substance

Isoproterenol

substance

Magnesium sulphate

substance

Magnesium sulfate anhydrous

substance

Research Evidence

Peer-reviewed studies linked via MeSH term "de Pointes, Torsades" from the MEDLINE/PubMed database.

Sort:

QT interval prolongation in acute antipsychotic poisoning: systematic review and recommendations.

[object Object], [object Object], [object Object] et al. · Clin Toxicol (Phila) · 2025

PMID: 41255343Meta-Analysis

QTc prolongation and torsades de pointes (TdP) in individuals undergoing methadone maintenance treatment (MMT): A systematic review and meta-analysis.

[object Object], [object Object], [object Object] et al. · Medicine (Baltimore) · 2025

PMID: 41137322Meta-AnalysisFull text (PMC)

QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic Review.

[object Object], [object Object], [object Object] et al. · Clin Lung Cancer · 2024

PMID: 38553324Meta-Analysis

Systematic review of long QT syndrome identified during fetal life.

[object Object], [object Object], [object Object] et al. · Heart Rhythm · 2023

PMID: 36566891Meta-Analysis

Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review.

[object Object], [object Object], [object Object] et al. · Eur J Clin Pharmacol · 2022

PMID: 35156131Meta-AnalysisFull text (PMC)

Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.

[object Object], [object Object], [object Object] et al. · Psychopharmacology (Berl) · 2021

PMID: 33410987Meta-AnalysisFull text (PMC)

Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.

[object Object], [object Object], [object Object] et al. · Eur J Clin Invest · 2021

PMID: 33043453Meta-AnalysisFull text (PMC)

Evaluation of the QT interval in patients with drug-induced QT prolongation and torsades de pointes.

[object Object], [object Object], [object Object] et al. · J Cardiovasc Electrophysiol · 2020

PMID: 32700358Meta-Analysis

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.

[object Object], [object Object], [object Object] et al. · Heart Rhythm · 2020

PMID: 32438018Meta-AnalysisFull text (PMC)

Validation and Clinical Utility of the hERG IC50:CRatio to Determine the Risk of Drug-Induced Torsades de Pointes: A Meta-Analysis.

[object Object], [object Object], [object Object] · Pharmacotherapy · 2018

PMID: 29380488Meta-Analysis

Search all PubMed articles for Torsades de pointes

Research data from MEDLINE/PubMed

Related Conditions

Torsade de pointes with short coupling interval syndrome(child)

Torsades de pointe caused by drug(child)

Ventricular tachycardia, polymorphic(parent)

Quick Facts

SNOMED CT: 31722008
UMLS CUI: C0040479
Fully Specified Name: Torsades de pointes (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
Known Treatments: 5

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.